Anti-Myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for jak/stat pathway inhibition in myeloma patients von de Oliveira, Mariana B, Fook-Alves, Veruska L, Eugenio, Angela I.P, Fernando, Rodrigo C, Sanson, Luiz Felipe G, de Carvalho, Mariana F, Braga, Walter M.T, Davies, Faith E, Colleoni, Gisele W.B

Volltext

Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly von Poles, Wagner A., Nishi, Erika E., de Oliveira, Mariana B., Eugênio, Angela I. P., de Andrade, Tathiana A., Campos, Antonio Hugo F. M., de Campos, Ruy R., Vassallo, José, Alves, Antonio C., Scapulatempo Neto, Cristovam, Paes, Roberto Antonio Pinto, Landman, Gilles, Zerbini, Maria Cláudia N., Colleoni, Gisele W. B.

Volltext